MEDICAL SERVICES & DEVICES
25
%
REDUCTION
IN MORTALITY RISK ASSOCIATED WITH USE OF ABBOTT’ S CARDIOMEMS DEVICE
Hospital-at-home programmes and virtual wards can use IoTenabled devices to track vital signs remotely, allowing clinicians to identify deterioration and intervene when necessary. The result is a shift from RPM as a tool for long-term disease management towards a connected extension of the hospital itself.
Broad corporate buy-in The biggest names in the medical device industry, including Philips, Medtronic, GE HealthCare, Abbott and Masimo, offer flagship RPM products that connect monitors, wearables and implantable devices to software platforms that can transmit physiological data to clinicians.
Medtronic, for example, has long used connected cardiac devices for remote monitoring, including through its MyCareLink Heart app, while GE
HealthCare’ s Portrait Mobile platform combines wearable monitoring with cloud-based connectivity. Philips is also integrating wearable biosensors into its patient-monitoring ecosystem.
The significance is that RPM is no longer simply about a bloodpressure cuff sending a reading to a smartphone. Increasingly, it is about interoperable ecosystems in which data from multiple devices can be brought together, analysed and incorporated into clinical workflows.
RPM’ s challenges The growth of RPM also brings two significant challenges: cybersecurity and capacity.
On the security front, moving monitoring into the home creates a much larger, distributed potential attack surface, with devices, cloud
66 October 2026